Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA
Nanoparticles coated with cell membranes have been garnering growing attention due to their homologous binding capability of membrane molecules and consequent self-recognition by their source cells. In the present study, we report on the construction of doxorubicin and PD-L1 siRNA-loaded PLGA nanopa...
Saved in:
Main Authors: | Mushi Chen, Ming Chen, Jiantai He |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1608219 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineering Lipid–Polymer Nanoparticles for siRNA Delivery to Cancer Cells
by: Arthur Manda, et al.
Published: (2025-06-01) -
Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
by: T. N. Sotnikova, et al.
Published: (2023-07-01) -
Chitosan-DNA/siRNA Nanoparticles for Gene Therapy
by: Shi, Qin, et al.
Published: (2011) -
Anti‐PD‐1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
by: Pooja Dhupkar, et al.
Published: (2018-06-01) -
Photothermal Therapeutic Gold Nanoparticles Loaded with PD-L1 siRNA Enhanced Killing of NSCLC Cells by Immune Cells
by: Gao L, et al.
Published: (2025-07-01)